Division of Hematology, Center for Biologics Evaluation and Research, Food and Drug Administration, 1401 Rockville Pike, HFM-345, Rockville, MD 20852, USA.
J Clin Microbiol. 2009 Nov;47(11):3427-34. doi: 10.1128/JCM.00373-09. Epub 2009 Sep 2.
Toll-like receptor (TLR)-expressing cells, for the first time, detected and identified a microbial contaminant in a product made in Escherichia coli using an old manufacturing process. It was suspected of having a microbial contaminant(s) because, although it tested negative by standard pyrogen assays, it was associated with adverse events in early clinical trials. The assay readout is the induction of NF-kappaB and/or cytokines in response to TLR activation. Four coded samples, labeled A to D, including a sample prepared by the older manufacturing process, were submitted. The cell lines were activated only by samples B and D. Sample D stimulated only Mono-Mac 6 and HEK-human TLR4 (hTLR4) cells and was later identified as lipopolysaccharide. Except for TLR3 cells, sample B stimulated cells bearing the different TLRs (TLRs 2, 4, 5, 7, 8, and 9) and nontransfected HEK293 cells. These data suggested that flagellin was the microbial contaminant, since TLR5, the receptor for flagellin, is known to be expressed constitutively on HEK293 cells. Moreover, purified flagellin from Salmonella enterica serovar Typhimurium behaved like sample B, stimulating HEK293 and HEK-hTLR5 cells but not HEK-hTLR3 cells, and this stimulation by flagellin and sample B was blocked by an anti-hTLR5 neutralizing antibody. Western blots showed bands positive for flagellin and sample B with the molecular sizes expected for the flagellins from S. Typhimurium and E. coli, respectively. Mass spectrometry data were consistent with the presence of flagellin in the manufacturer's sample B. Taken together, these data indicate that the microbial contaminant in sample B was flagellin and may have been associated with adverse events when the recombinant product was administered.
Toll 样受体 (TLR)-表达细胞首次检测并鉴定出一种使用旧制造工艺生产的大肠杆菌产品中的微生物污染物。它被怀疑含有微生物污染物,因为尽管它通过标准热原检测呈阴性,但它与早期临床试验中的不良事件有关。该检测的结果是 TLR 激活后 NF-κB 和/或细胞因子的诱导。提交了四个编码样本,标记为 A 到 D,包括一个使用旧制造工艺制备的样本。只有样本 B 和 D 能激活细胞系。样本 D 仅刺激单核细胞-巨噬细胞 6 和 HEK-人 TLR4(hTLR4)细胞,后来被鉴定为脂多糖。除了 TLR3 细胞外,样本 B 还刺激携带不同 TLR(TLR2、4、5、7、8 和 9)和非转染的 HEK293 细胞的细胞。这些数据表明鞭毛蛋白是微生物污染物,因为 TLR5 是鞭毛蛋白的受体,已知在 HEK293 细胞中持续表达。此外,从鼠伤寒沙门氏菌血清型 Typhimurium 中纯化的鞭毛蛋白的行为与样本 B 相似,刺激 HEK293 和 HEK-hTLR5 细胞,但不刺激 HEK-hTLR3 细胞,鞭毛蛋白和样本 B 的这种刺激被抗 hTLR5 中和抗体阻断。Western blot 显示鞭毛蛋白和样本 B 的条带呈阳性,分子量分别与来自鼠伤寒沙门氏菌和大肠杆菌的鞭毛蛋白的预期分子量一致。质谱数据与制造商样本 B 中存在鞭毛蛋白一致。综上所述,这些数据表明,样本 B 中的微生物污染物是鞭毛蛋白,当重组产品给药时,可能与不良事件有关。